lipogen duo vet -
elanco europe ltd - aeromonas salmonicida subspesie salmonicida, inaktivert / vibrio anguillarum serotype o1, inaktivert - injeksjonsvæske, emulsjon
veloxa 175 mg / 504 mg / 525 mg
lavet pharmaceuticals ltd. - prazikvantel / pyrantelembonat / febantel - tyggetablett - 175 mg / 504 mg / 525 mg
veloxa 50 mg / 144 mg / 150 mg
lavet pharmaceuticals ltd. - prazikvantel / pyrantelembonat / febantel - tyggetablett - 50 mg / 144 mg / 150 mg
zepromec 5 mg/ ml
chanelle pharmaceuticals manufacturing ltd - eprinomektin - påhellingsvæske, oppløsning - 5 mg/ ml
vectormune fp ilt + ae
ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - kylling - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.
vectormune fp ilt
ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kylling - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.
lacosamide adroiq
extrovis eu ltd. - lakosamid - epilepsi - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
enzepi
allergan pharmaceuticals international ltd - bukspyttkjertelpulver - eksokrine bukspyttkjertelinsuffisiens - fordøyelsesmidler, inkl. enzymer - behandling av kreft i bukspyttkjertelen i eksokrin pankreatisk insuffisiens på grunn av cystisk fibrose eller andre forhold (e. kronisk pankreatitt, etter pankreatektomi eller kreft i bukspyttkjertelen). enzepi er angitt i spedbarn, barn, ungdom og voksne.
hiprabovis ibr marker live
laboratorios hipra s.a - levende ge- tk-dobbeltgen-slettet bovint herpesvirus type 1, stamme ceddel: 106,3-107,3 ccid50 - immunologicals - kveg - for aktiv immunisering av storfe fra tre måneders alder mot bovin herpesvirus type 1 (bohv-1) for å redusere de kliniske tegnene på infeksiøs bovin rhinotracheitt (ibr) og feltvirusutskillelse. immunitetens begynnelse: 21 dager etter at grunnvaksinasjonsordningen er fullført. immunitetens varighet: 6 måneder etter at grunnvaksinasjonsordningen er fullført.
intrinsa
warner chilcott uk ltd. - testosteron - seksuelle dysfunksjoner, psykologisk - sex hormoner og modulatorer av genital systemet, - intrinsa er indisert for behandling av hypoactive seksuell lyst lidelse (hsdd) i bilateralt oophorectomised og hysterectomised (kirurgisk indusert overgangsalder) kvinner mottar samtidig estrogen terapi.